Page 182 - Essential Haematology
P. 182

168  /  Chapter 12  Haematological malignancy: management


                      significant problem in stem cell transplant recipi-      Antiemetic therapy

                      ents (see  p. 309     ).
                                                               Nausea and vomiting are common side - eff ects  of
                       5   Red cell transfusions should be avoided if at all



                                                              chemotherapy. A key objective is to try to prevent
                      possible in patients with a very high white cell   nausea occurring early in the treatment as it is more
                                    9
                      count ( > 100    ×    10  /L) because of the hypervis-
                                                              difficult to control once problems have arisen. Th e


                      cosity and the risk of precipitating thrombotic
                                                              5 - HT  3   (serotonin) receptor antagonists such as
                      episodes as a result of white cell stasis.
                                                              ondansetron or granisetron can control nausea from
                       6      Large volume transfusions, such as 3 units of
                                                              intensive chemotherapy in over 60% of cases and
                      blood or more, can precipitate pulmonary
                                                              the addition of dexamethasone can increase this by
                      oedema in older patients and should be given
                                                              approximately 20%. Metoclopramide, prochlorper-
                      slowly and with clinical monitoring. Diuretics
                                                              azine or cyclizine, benzodiazepines (e.g. lorazepam),
                      such as frusemide (furosemide) are often given.
                                                              domperidone or cannabinoids (e.g. nabilone) can



                       7   Febrile reactions with blood products are not
                                                              all have a role.
                      uncommon and should be managed by slowing
                      the infusion and administration of drugs such as
                      antihistamines, pethidine or hydrocortisone. Th e       Tumour lysis syndrome
                      dosage of steroids should be limited because of     Chemotherapy may trigger an acute rise in plasma
                      concerns with immunosuppression.        uric acid, potassium and phosphate and cause
                       8      Blood products given to highly immunosup-  hypocalcaemia because of rapid lysis of tumour
                      pressed patients (e.g. from chemotherapy, such as   cells. This syndrome is seen most commonly with


                      fludarabine, with aplastic anaemia, Hodgkin   rapidly dividing tumours such as lymphoblastic
                      lymphoma or post - allogeneic SCT) should be   lymphoma or acute leukaemia and can cause acute
                      irradiated prior to administration to prevent   renal failure. Allopurinol, intravenous fl uids  and
                      graft - versus - host disease (see  p. 306     ).    electrolyte replacement are the mainstay of preven-
                       9      The use of recombinant erythropoietin to reduce   tion and alkalinization of the urine is sometimes

                      the need for blood transfusion and improve   used. Rasburicase, an enzyme that oxidises uric acid
                      patient well - being (e.g. in myeloma or myelod-  to allantoin, is highly effective in controlling

                      ysplasia) is discussed on  p. 18   .         hyperuricaemia.
                        Haemostasic support                       Psychological support
                      A coagulation screen should be performed regularly     Patients with a diagnosis of malignant disease com-
                    on patients undergoing intensive chemotherapy and   monly feel concerns about such issues as the dis-

                    support with vitamin K or FFP may be required.   comfort of treatment, finance, sexuality and fear of
                    Cryoprecipitate may be needed for fi brinogen defi -  mortality. Even when patients achieve a clinical
                    ciency (e.g. precipitated by asparaginase in the man-  remission there is understandable concern about
                    agement of acute lymphoblastic leukaemia; ALL).   the chance of disease relapse. Psychological support
                    Antiplatelet drugs such as aspirin or clopidogrel are   should be an integral part of the relationship
                    usually discontinued in patients undergoing inten-  between physician and patient, and patients should
                    sive chemotherapy and patients on long - term war-  be allowed to express their fears and concerns at the
                    farin can be switched to low molecular weight   earliest opportunity. Most patients value the oppor-
                    heparin, which can then itself be stopped if the   tunity to read more about their disorder and many
                                             9
                    platelet count falls below 50    ×    10  /L. Progesterones   excellent booklets or websites are now available.
                    are given to premenopausal women undergoing   Teamwork is also crucial and the nursing staff  and
                    intensive chemotherapy to prevent menstruation.   trained counsellors have a vital role in off ering
                    Tranexamic acid can be given to reduce haemor-  support and information during inpatient and out-
                    rhage in patients with chronic low - grade blood   patient care. Many units have specialist input from
                    loss.                                     clinical psychologists and psychiatric help may
   177   178   179   180   181   182   183   184   185   186   187